Stocklytics Platform
Asset logo for symbol CSTL
Castle Biosciences
CSTL65
$28.26arrow_drop_up2.41%$0.66
Asset logo for symbol CSTL
CSTL65

$28.26

arrow_drop_up2.41%

Performance History

Chart placeholder
Key Stats
Open$26.39
Prev. Close$27.60
EPS0.21
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range26.39
29.87
52 Week Range12.07
36.00
Ratios
EPS0.21

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Castle Biosciences (CSTL)

Castle Biosciences Inc, also known as CSTL, is a leading precision medicine company specializing in the development and commercialization of genomic-driven tests for cancers. The company focuses on providing accurate and personalized diagnostic and prognostic information to healthcare providers and patients. Castle Biosciences' innovative tests are designed to aid in treatment decisions, improve patient outcomes, and reduce healthcare costs.
With a strong commitment to research and development, Castle Biosciences has developed a diverse portfolio of genomic tests that cover a wide range of cancers. These tests utilize advanced molecular and bioinformatic technologies to analyze the genetic and molecular characteristics of tumors, enabling tailored treatment strategies for each patient. The company's tests have been clinically validated and are supported by robust data and evidence.
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Derek J. Maetzold
Headquarters
Friendswood
Employees
582
Exchange
NASDAQ
add Castle Biosciences  to watchlist

Keep an eye on Castle Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Castle Biosciences 's (CSTL) price per share?

The current price per share for Castle Biosciences (CSTL) is $28.27. The stock has seen a price change of $0.67 recently, indicating a 2.41% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Castle Biosciences (CSTL)?

For Castle Biosciences (CSTL), the 52-week high is $36, which is 27.36% from the current price. The 52-week low is $12.07, the current price is 134.18% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Castle Biosciences (CSTL) a growth stock?

Castle Biosciences (CSTL) has shown an average price growth of 0.63% over the past three years. It has received a score of 26 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Castle Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Castle Biosciences (CSTL) stock price performance year to date (YTD)?

As of the latest data, Castle Biosciences (CSTL) has a year-to-date price change of 6.06%. Over the past month, the stock has experienced a price change of -6.56%. Over the last three months, the change has been -16.32%. Over the past six months, the figure is 5.35%. Looking at a longer horizon, the five-year price change stands at -5.59%.
help

Is Castle Biosciences (CSTL) a profitable company?

Castle Biosciences (CSTL) has a net income of -$57.47M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 79.53% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 5.92% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $219.79M, with a revenue growth rate of 60.38%, providing insight into the company's sales performance and growth. The gross profit is $174.81M. Operating income is noted at -$67.98M. Furthermore, the EBITDA is $25.08M.
help

What is the market capitalization of Castle Biosciences (CSTL)?

Castle Biosciences (CSTL) has a market capitalization of $773M. The average daily trading volume is 26.68, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level